Survival rate of colorectal cancer in China: A systematic review and meta-analysis
Frontiers in Oncology · 03.03.2023 · 13
DOI: 10.3389/fonc.2023.1033154 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Oncology, online erschienen am 03.03.2023. Verfasst von Ren Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Outpatient Chemotherapy, Harbin Medical University Cancer Hospital, Harbin, China. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Wu Jieping Medical Foundation, Heilongjiang Provincial Postdoctoral Science Foundation.
Abstract (Originalsprache)
Background
This study aims to comprehensively summarize the colorectal survival rate in China.
Method
In PubMed and Web of Science, keywords such as “colorectal cancer”, “survival” and “China” were used to search literatures in the past 10 years. Random effect models were selected to summarize 1-year, 3-year, and 5-year survival rates, and meta-regression and subgroup analyses were performed on the included studies.
Results
A total of 16 retrospective and prospective studies providing survival rates for colorectal cancer in China were included. The 1-year, 3-year, and 5-year survival rates of colorectal cancer in China were 0.79, 0.72 and 0.62, respectively. In the included studies, the 5-year survival rates of stage I (5474 cases), stage II (9215 cases), stage III (8048 cases), and stage IV (4199 cases) colorectal cancer patients were 0.85, 0.81, 0.57 and 0.30, respectively. Among them, the 5-year survival rates of colorectal cancer were 0.82, 0.76, 0.71, 0.67, 0.66, 0.65 and 0.63 in Tianjin, Beijing, Guangdong, Shandong, Liaoning, Zhejiang and Shanghai, respectively.
Conclusion
The 5-year survival rate in China is close to that of most European countries, but still lower than Japan and South Korea, and the gap is gradually narrowing. Region, stage, differentiation, pathological type, and surgical approach can affect 5-year survival in colorectal cancer. Systematic review registration https://www.crd.york.ac.uk/prospero/ identifier, CRD42022357789.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Outpatient Chemotherapy, Harbin Medical University Cancer Hospital, Harbin, China.
Förderung
- National Natural Science Foundation of China
- Wu Jieping Medical Foundation
- Heilongjiang Provincial Postdoctoral Science Foundation
- China Postdoctoral Science Foundation
Zitieren
APA
Wang, R., Lian, J., Wang, X., Pang, X., Xu, B., Tang, S., Shao, J., & Lu, H. (2023). Survival rate of colorectal cancer in China: A systematic review and meta-analysis. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1033154
Vancouver
Wang R, Lian J, Wang X, Pang X, Xu B, Tang S, et al. Survival rate of colorectal cancer in China: A systematic review and meta-analysis. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1033154
BibTeX
@article{Wang2023,
author = {Wang, Ren and Lian, Jie and Wang, Xin and Pang, Xiangyi and Xu, Benjie and Tang, Shuli and Shao, Jiayue and Lu, Haibo},
title = {Survival rate of colorectal cancer in China: A systematic review and meta-analysis},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1033154}
}
EUVIMED